Bioactivity:

Riviciclib is a potent inhibitor of cyclin-dependent kinase (CDK)(CDK9-cyclinT1, CDK4-cyclin D1, and CDK1-cyclinB with IC50s of 20 nM, 63 nM, and 79 nM, respectively),with antitumor activity on cisplatin-resistant cells.

CAS nr:

920113-02-6

Purity:

98%

Molecular Weight:

401,84

SMILES:

O=C1C=C(C2=C(Cl)C=CC=C2)OC3=C([C@H]4[C@H](CO)N(C)CC4)C(O)=CC(O)=C13

Formula:

C21H20ClNO5

Pathway:

Others

Target:

Others